3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Primary Myelofibrosis
12
Polycythemia Vera
11
Myelodysplastic Syndromes
10
Leukemia
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Myeloproliferative Disorders
8
Recurrence
6
Leukemia, Myelomonocytic, Chronic
6
Hematologic Neoplasms
6
Breast Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
5
Lymphoma, T-Cell
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Graft vs Host Disease
5
Thrombocythemia, Essential
4
Leukemia, Myeloid, Chronic-Phase
4
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia, Prolymphocytic, T-Cell
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Interventions
Etoposide
7
pegaspargase
5
Methylprednisolone
4
Dexamethasone
4
Cyclophosphamide
3
Alemtuzumab
3
Gemcitabine
2
Doxorubicin
2
zanubrutinib
1
tocilizumab
1
sintilimab
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Thiotepa
1
Th1-Th2 Balance
1
Tacrolimus
1
Rituximab
1
Prednisone
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Melphalan
1
Flow Cytometry
1
EPOCH protocol
1
Cytarabine
1
Cisplatin
1
Calcium Dobesilate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphohistiocytosis, Hemophagocytic
×
ruxolitinib
×
Clear all
NCT04999878
2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4
Unknown
30 enrolled